ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $301,608,000 | +69.9% | 6,509,988 | -10.6% | 0.02% | +57.1% |
| Q1 2019 | $177,484,000 | +71.6% | 7,279,920 | +0.3% | 0.01% | +55.6% |
| Q4 2018 | $103,408,000 | -23.9% | 7,256,734 | -18.8% | 0.01% | -10.0% |
| Q3 2018 | $135,802,000 | +5.4% | 8,934,436 | +16.3% | 0.01% | -9.1% |
| Q2 2018 | $128,888,000 | -1.0% | 7,681,261 | -3.7% | 0.01% | 0.0% |
| Q1 2018 | $130,142,000 | +9.3% | 7,974,694 | -14.3% | 0.01% | +10.0% |
| Q4 2017 | $119,100,000 | +29.9% | 9,304,834 | +24.9% | 0.01% | +25.0% |
| Q3 2017 | $91,666,000 | +14.7% | 7,452,415 | -21.9% | 0.01% | +14.3% |
| Q2 2017 | $79,890,000 | +8.1% | 9,544,525 | +15.5% | 0.01% | 0.0% |
| Q1 2017 | $73,882,000 | +30.8% | 8,264,775 | +28.6% | 0.01% | +40.0% |
| Q4 2016 | $56,498,000 | +84.2% | 6,427,728 | +41.4% | 0.01% | +66.7% |
| Q3 2016 | $30,679,000 | +141.9% | 4,544,479 | +27.5% | 0.00% | +200.0% |
| Q2 2016 | $12,683,000 | -10.7% | 3,563,329 | -26.0% | 0.00% | -50.0% |
| Q1 2016 | $14,196,000 | -30.0% | 4,812,664 | +0.1% | 0.00% | 0.0% |
| Q4 2015 | $20,294,000 | -31.1% | 4,809,038 | -25.6% | 0.00% | -33.3% |
| Q3 2015 | $29,466,000 | -27.7% | 6,461,332 | +14.3% | 0.00% | -25.0% |
| Q2 2015 | $40,757,000 | +13.5% | 5,653,077 | +16.0% | 0.00% | 0.0% |
| Q1 2015 | $35,903,000 | +56.8% | 4,871,611 | +0.6% | 0.00% | +100.0% |
| Q4 2014 | $22,899,000 | +1.3% | 4,841,504 | -23.6% | 0.00% | 0.0% |
| Q3 2014 | $22,608,000 | -5.8% | 6,333,937 | +20.4% | 0.00% | -33.3% |
| Q2 2014 | $23,988,000 | -7.5% | 5,260,401 | -4.6% | 0.00% | 0.0% |
| Q1 2014 | $25,928,000 | -31.7% | 5,516,395 | -35.1% | 0.00% | +50.0% |
| Q4 2013 | $37,949,000 | +15.3% | 8,499,126 | +60.7% | 0.00% | -50.0% |
| Q3 2013 | $32,903,000 | +78.8% | 5,289,670 | +30.5% | 0.00% | +100.0% |
| Q2 2013 | $18,405,000 | – | 4,054,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|